RT Journal Article
T1 Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats’ disease
A1 Dorado, Ana María
A1 De Pablo Cabrera, Almudena
A1 Muñoz Gallego, Alicia
A1 Moreno García, Luís
A1 Barceló Mendiguchía, Ana
A1 Tejada Palacios, Pilar
AB We report two cases of stage 3A unilateral Coats’ disease in pediatric patients. In both cases, disease control was achieved using a dexamethasone intravitreal implant in addition to other treatments. The treatment improved visual acuity in one patient and prevented the worsening of the decline in visual acuity in the other patient during follow-up periods of 7 and 3 years, respectively. One of the patients presented an increase in intraocular pressure, which was controlled with topical antiglaucoma medication, but developed a cataract that required surgery. In conclusion, dexamethasone intravitreal implant may be a useful adjuvant treatment to consider in some pediatric cases with Coats’ disease
PB Conselho Brasileiro de Oftalmologia
SN 0004-2749
YR 2023
FD 2023
LK https://hdl.handle.net/20.500.14352/92511
UL https://hdl.handle.net/20.500.14352/92511
LA eng
NO Dorado, A. M., De Pablo Cabrera, A., Muñoz Gallego, A. et al. «Dexamethasone Intravitreal Implant as an Adjuvant Treatment for Pediatric Patients with Coats’ Disease». Arquivos Brasileiros de Oftalmologia, vol. 86, marzo de 2022, pp. 380-83. SciELO, https://doi.org/10.5935/0004-2749.20230028.
DS Docta Complutense
RD 21 dic 2025